Bio-Gene Technology Ltd. Stock Analysis BGT.AX

Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. Its products are based on a naturally occurring class of compounds proven to overcome resistance to control pests with minimal impact on human health and the environment. Its products have multiple applications across crop protection, grain storage, public health and consumer uses. Flavocide and Qcide are the Company’s lead beta-triketone insecticide products. Flavocide is a natural beta-triketone molecule produced synthetically by a chemical process. Qcide is a natural oil product containing tasmanone as the active constituent. The oil is extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana), by utilizing a steam distillation process. The firm operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.